clarithromycin has been researched along with Bisphosphonate Osteonecrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zadik, Y | 1 |
1 other study(ies) available for clarithromycin and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients.
Topics: Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clarithromycin; Drug Administration Schedule; Humans; Multiple Myeloma; Osteolysis | 2018 |